Argos Therapeutics Named as a Red Herring Top 100 North

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Argos Therapeutics Named as a Red Herring Top 100 North America Winner

DURHAM, N.C., May 27, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq: ARGS ), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that the company has been selected as a Red Herring Top 100 North America winner. Each year Red Herring, a technology and business magazine and online news source, honors 100 outstanding entrepreneurs and promising companies as award winners from among approximately 3,000 companies financed annually in the US and Canada.

"This year has so far been momentous for Argos Therapeutics, including completion of our initial public offering, continued progress in our ADAPT pivotal Phase 3 clinical trial, presentation of long-term survival data from our Phase 2 trial for AGS-003 in the treatment of metastatic renal cell carcinoma, and continued progress on our clinical program for AGS-004 in the treatment of HIV. We are proud to have our many positive developments this year recognized through our selection as a Red Herring Top 100 winner," said Jeff Abbey, president and CEO at Argos.

Argos will be presenting the results of its completed Phase 2 combination study and ongoing pivotal ADAPT trial involving AGS-003—the company's investigational fully personalized immunotherapy for cancer—plus standard targeted therapy in poster sessions during the American Society of Clinical Oncology (ASCO) annual meeting, taking place May 30 – June 2 in Chicago.

In the award selection process, Red Herring's editorial staff evaluates companies on both quantitative and qualitative criteria such as financial performance, technological innovation, intellectual property, management quality, business model, customer footprint, and market penetration. This assessment of potential is complemented by a review of the track record and standing of startups relative to their sector peers.

About Argos Therapeutics

Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform. Argos' most advanced product candidate, AGS-003, is being evaluated in the pivotal ADAPT Phase 3 clinical trial for the treatment of metastatic renal cell carcinoma (mRCC). The company also plans to report data from its Phase 2b trial of AGS-004 for the treatment of HIV in mid-2014. For more information about Argos Therapeutics, visit www.argostherapeutics.com .

Media: Jen Ringler Berry & Company Public Relations (212) 253-8881 Investors: Angeli Kolhatkar Burns McClellan (212) 213-0006

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bybit Expands ByPick Game with Broader Market Reach

Updated Category News Views 136

Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...

Continue Reading
Zoomlion Unveils AI-Powered Gear at bauma CHINA 2026

Updated Category News Views 283

Setting the Stage for AI in Construction Now here's a scene that's hard to ignore—Zoomlion strutting its stuff at bauma CHINA 2026, putting over 60 examples of its AI-powered, new-energy technologies front and center. It's not every day we see a massive leap this big in the industry, and this November in Shanghai, Zoomlion's got plans to make sure we don't quickly...

Continue Reading
DraftKings Shares Tumble, Investors Grapple with Losses

Updated Category News Views 60

DraftKings' Bold Moves Hit Investor Pockets Hard It ain't every day you see a company gamble nearly $700 million and come out with egg on its face. Yet, that's what DraftKings (NASDAQ: DKNG) seems to have done, and now it's shareholders who might be left holding the bag. On November 6, 2026, when DraftKings admitted it was doubling down on its Predictions business...

Continue Reading
Revolutionary Sports Ball Backpack: A Game Changer?

Updated Category News Views 37

Backpacks Reinvented by a Clever Mom Ever been caught in the whirlwind of juggling kids, sports gear, and school supplies? Well, one stay-at-home mom from Poway, California found herself in just such a predicament. She turned this everyday chaos into a creative solution by designing a unique Sports Ball Backpack. The idea came to her while managing a toddler, a newborn,...

Continue Reading
$10,000 Boost Fuels Nichols College's Archaeological Quest

Updated Category News Views 178

Webster First's Generous Contribution It's not every day you see a credit union digging into history—literally. Webster First Federal Credit Union just dropped ten grand to fuel Nichols College's archaeological adventures. This isn't some trivial check to post on Instagram. No, we're talking about funding some serious ground-penetrating radar (GPR) gadgetry that's set...

Continue Reading
Understanding Septic Tank Pumping: Insights & Tips

Updated Category News Views 98

Why in the world are we discussing septic tanks today? Well, it’s because folks often overlook their importance until they’re knee-deep in unexpected plumbing woes. If you're a homeowner, understanding your septic system's needs is crucial to avoid literal and financial messes down the line. Behind the Scenes of Your Septic System Picture your household water usage....

Continue Reading
YYForce Expands in UAE with Key Hospitality Wins

Updated Category News Views 170

Unveiling YYForce's Middle East Strategy Smack in the middle of an aggressive Middle Eastern expansion, YYForce (NASDAQ: YFOR) is making waves with some new headline-grabbing contracts in the UAE. This ain't just a side hustle—it's big time. They're planting their flag across the luxury hospitality sector like they're going for a moon landing. The recent announcement...

Continue Reading
Biodiversity Monitoring Poised for $11.39 Billion Boom

Updated Category News Views 193

A Billion-Dollar Market on the Rise Picture this: you're watching the world make a monumental shift towards sustainability in real-time. The biodiversity monitoring market is on a gallop, poised to grow from a modest USD 7.17 billion in 2026 to a hearty USD 11.39 billion by 2031. That's a CAGR of 9.7%—a pace that soothes the nerves of any investor weary of the whims of...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 96

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Anderson University Sees Financial Turnaround Success

Updated Category News Views 153

Anderson University, against all odds, is shaking up the financial narrative they’ve been stuck in for a while. It’s kind of like finding a $20 bill in an old coat—a nice surprise but it doesn’t happen every day. The university’s recent report on their financial progress is reminding folks that when it comes to fiscal discipline, sometimes you just need fresh...

Continue Reading

Top 5 Most Recently Viewed Articles

Mike Reynolds Elevates National Park Foundation Efforts

Updated Category News Views 50

Seasoned Leadership for National Park Foundation Well, here's a shakeup you don't see every day: Mike Reynolds, with more than four decades under his belt at the National Park Service (NPS), is now steering the ship over at the National Park Foundation (NPF) as their Chief Program Officer. In the nonprofit game, leadership's half the battle, and this veteran's set to roll...

Continue Reading
CM Seven Star Acquisition Faces Significant Challenges and Losses

Updated Category News Views 159

CM Seven Star Acquisition Corporation’s Stock Decline CM Seven Star Acquisition Corporation (NASDAQ: KXIN) has faced an incredibly challenging year, marked by significant stock price declines, with its shares recently hitting a 52-week low of $2.26. This steep drop of 97.96% demonstrates the company’s overwhelming struggles in a volatile market, reflecting broader...

Continue Reading
OpenText Wins 2025 SAP Pinnacle Award for Excellence in Solutions

Updated Category News Views 370

OpenText Achieves Recognition with the 2025 SAP Pinnacle Award OpenText has recently been celebrated for its exceptional performance as an SAP partner by receiving the prestigious 2025 SAP Pinnacle Award in the Partner Solution Success category. This award is a testament to OpenText’s sustained commitment to delivering top-quality solutions that help businesses maximize...

Continue Reading
Copper Supply Disruption Raises Prices Amid Market Volatility

Updated Category News Views 254

Copper Market Faces Uncertain Future The copper market is currently undergoing a significant shake-up due to unexpected disruptions at the Grasberg mine in Indonesia. These disturbances are causing ripples across supply forecasts and price expectations, leading to heightened concerns in the industry. Grasberg Mine Disruptions The operator at Grasberg has declared force...

Continue Reading
Faraday Future Intelligent Electric Stock Sees Notable Rise

Updated Category News Views 111

Faraday Future Intelligent Electric Stock Update Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) shares are experiencing a notable increase as the company has announced a significant acquisition. The latest development involves receiving a 10% stake in Grow Fandor, which has positively influenced investor sentiment. Details of the Recent Acquisition The stake in...

Continue Reading